<DOC>
	<DOCNO>NCT02655302</DOCNO>
	<brief_summary>Chronic obstructive pulmonary disease ( COPD ) worldwide chronic inflammatory disease airways link environmental exposure . The chronic course COPD often interrupt acute exacerbation major impact morbidity mortality COPD patient . A bacterial etiology exacerbation common ( almost 50 % ) . Moreover , airway bacterial colonization link increased susceptibility observe COPD patient . Effective Th17 immune response need develop good response bacteria . Thus , study aim demonstrate defective IL-17/ IL-22 response bacteria COPD lead airway bacterial colonization infection .</brief_summary>
	<brief_title>Study Involvement IL-17 / IL-22 Pathway Bacterial Exacerbations COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Diagnosed COPD accord GOLD guideline Current exsmoker ( least 10 packyears ) Hospitalized COPD exacerbation Asthma Cystic fibrosis No chronic lung disease Solid Tumor unhealed consider remission Inhaled drug consumption Women childbearing potential without effective contraception Pregnant breastfeed woman Incapable consent Lack social security coverage</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Interleukin-17</keyword>
	<keyword>Interleukin-22</keyword>
	<keyword>Microbiota</keyword>
	<keyword>Exacerbations</keyword>
	<keyword>Immunity</keyword>
	<keyword>Mucosal</keyword>
</DOC>